IT Earnings Season: A Muted Start But Hints of a 2026 AI Boom - Professional coverage
AIBusinessSoftware

IT Earnings Season: A Muted Start But Hints of a 2026 AI Boom

According to Bloomberg Business, the upcoming earnings season for major IT firms is expected to be muted but could offer…

MIT's 2026 Tech Forecast: From AI Companions to Greener Grids - Professional coverage
AIInnovationSoftware

MIT’s 2026 Tech Forecast: From AI Companions to Greener Grids

According to Forbes, MIT Technology Review has outlined the major tech trends to watch in 2026, focusing on energy, AI,…

AI Isn't a Mind. It's a Market. And That's a Bigger Deal. - Professional coverage
AIBusinessInnovation

AI Isn’t a Mind. It’s a Market. And That’s a Bigger Deal.

According to Bloomberg Business, a group of social and cognitive scientists is pushing a provocative new metaphor for understanding artificial…

AIBlockchain

Decentralized AI Agents Emerge as Counterweight to Centralized Crypto Automation

The rapid expansion of AI agents in cryptocurrency markets has sparked concerns about centralized control in decentralized ecosystems. While most agents rely on proprietary AI models, a growing movement advocates for transparent, verifiable alternatives that preserve Web3’s core values.

The Rise of AI Agents in Crypto Markets

The cryptocurrency sector is reportedly experiencing what industry analysts suggest could be its most significant transformation since the advent of browser wallets, with autonomous AI agents ballooning from experimental novelty to a $13.5 billion market virtually overnight. According to reports, over 11,000 AI agents now operate on the Virtuals Protocol platform alone, executing trades and managing portfolios with minimal human oversight. The phenomenon gained mainstream attention when Truth Terminal, an AI agent, reportedly convinced venture capitalist Marc Andreessen to donate $50,000, launching the $GOAT token to a $1.2 billion market cap.

HealthcareInnovation

Lab-Grown Embryo Models Produce Functional Blood Cells in Scientific Breakthrough

Scientists have created embryo-like structures that function as miniature blood factories, producing both red and white blood cells in laboratory conditions. This breakthrough could eventually help address shortages in blood donations for patients with blood disorders, according to researchers at the University of Cambridge.

Scientific Breakthrough in Blood Cell Production

Researchers have developed embryo-like structures that can produce human blood cells in laboratory conditions, according to reports from the University of Cambridge. The team behind the innovation calls these tiny blood factories ‘hematoids,’ which sources indicate could one day supplement traditional blood donations for patients with conditions like leukemia and lymphoma.